Stockscreener 앱 받기
2.50
3.10%
-0.08
시장 영업 전:
2.50
C 4 Therapeutics Inc 주식(CCCC)의 최신 뉴스
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics 2025 Q2 Earnings Widened Losses Amid Mixed Price Performance - AInvest
Spotlight On 3 Intriguing Penny Stocks With Market Caps As Low As $100M - simplywall.st
C4 Therapeutics Reports Q2 2025 Financial Results - TipRanks
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics Q2 2025 Financial Results: Revenue Down to $6.5M, Cash Position at $223M - AInvest
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
C4 Therapeutics, Inc. SEC 10-Q Report - TradingView
C4 Therapeutics reports Q2 2025 results, cemsidomide Phase 1 data accepted at IMS. - AInvest
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2025 - BioSpace
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
What drives C4 Therapeutics Inc. stock priceBuild wealth faster with disciplined trading - Jammu Links News
Is it the right time to buy C4 Therapeutics Inc. stockGet daily updates on promising stocks - Jammu Links News
What makes C4 Therapeutics Inc. stock price move sharplyCapitalize on momentum-driven stocks - Jammu Links News
What is C4 Therapeutics Inc. company’s growth strategyMaximize returns with strategic trading plans - Jammu Links News
When is C4 Therapeutics Inc. stock expected to show significant growthGet timely alerts on top market movers - Jammu Links News
What is the dividend policy of C4 Therapeutics Inc. stockUnlock daily trading alerts for profits - Jammu Links News
Is C4 Therapeutics Inc. stock overvalued or undervaluedSuperior stock growth - Jammu Links News
Why is C4 Therapeutics Inc. stock attracting strong analyst attentionUnmatched market performance - Jammu Links News
Is C4 Therapeutics Inc. a growth stock or a value stockFree Capital Allocation Plans - Jammu Links News
What are C4 Therapeutics Inc. company’s key revenue driversGet alerts on high-potential market moves - Jammu Links News
What is the risk reward ratio of investing in C4 Therapeutics Inc. stockAchieve breakthrough investment performance - Jammu Links News
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress
What are the latest earnings results for C4 Therapeutics Inc.Invest confidently with professional market insights - Jammu Links News
What are analysts’ price targets for C4 Therapeutics Inc. in the next 12 monthsInvest confidently with market-leading analysis - Jammu Links News
Here's What Analysts Are Forecasting For C4 Therapeutics, Inc. (NASDAQ:CCCC) After Its First-Quarter Results - 富途牛牛
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Xilio Therapeutics Awards $87K Worth of Stock Options in Key Employee Inducement Plan - Stock Titan
Protara Therapeutics Grants $45K Worth of Stock Options and RSUs to Strategic New Employees - Stock Titan
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Intellia Therapeutics Expands Team with Strategic Stock Grants Worth 18,200 Shares - Stock Titan
Does C4 Therapeutics Inc. stock perform well during market downturnsAdvanced Screener Report With High Returns - Jammu Links News
Sentiment analysis tools applied to C4 Therapeutics Inc.Short Term Setup With Predictive Chart Confirmed - metal.it
C4 Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
New Product Launches: Will They Boost C4 Therapeutics Inc. Stock in 2025Community Strategy With High Win Rate Backtested - metal.it
Published on: 2025-07-29 21:44:21 - metal.it
0.24%
3.39%
자본화:
|
볼륨(24시간):